top of page
Management of chronic kidney disease and heart disease is changing rapidly
WIDE IMPACT
Kidney disease and/or
heart disease affects 2 in 7
HUGE ECONOMICS
$2B every week spent by US Medicare alone
TRANSITION TO VALUE-BASED CARE
Improved outcomes; reduced cost of care
In kidney disease or heart failure, important blood markers like potassium, magnesium and calcium are currently only tested in clinical settings
Reliance on venous blood testing makes it impossible to use real-time data to personalised treatments
Personalised monitoring is currently impossible
We're making active monitoring possible
Simple and easy to use by patients or clinicians
Rapid and minimally invasive - no more delayed results
Accurate self-testing for a new standard of care
bottom of page